Federal Vaccine Advisory Committee Alters Hepatitis B Vaccine Recommendation

NEW YORK (AP) – The federal Vaccine Advisory Committee has decided to withdraw its long-standing recommendation for all infants in the U.S. to receive the hepatitis B vaccine at birth.

This decision has drawn criticism from many medical and public health professionals. The committee’s current members were appointed by U.S. Secretary of Health Robert F. Kennedy Jr., who had previously been known as a prominent anti-vaccine activist before taking on this role.

Dr. William Schaffner, a vaccine expert from Vanderbilt University, expressed concern, saying that the committee is difficult to challenge.

While the committee made this change, several medical organizations and state health departments remain committed to recommending the birth dose of the vaccine. The group representing health insurance providers indicated that coverage for the vaccine at birth will continue as well.

For many years, health authorities have advised immediate vaccination for infants to prevent liver infections, a strategy seen as effective in reducing disease occurrences. However, the new guideline suggests that only infants whose mothers are infected, or those whose maternal status is unknown, should be vaccinated at birth. Parents of other infants may decide in consultation with their doctors whether to postpone the vaccination.

The committee voted 8-3 to endorse this change, suggesting that if families opt to delay, the vaccination series should begin when the child is two months old.

President Trump praised the committee’s decision as a positive move.

The final decision rests with Jim O’Neill, the acting director of the CDC.

A Shift in Health Strategy

When asked about the quick shift in policy, committee member Vicki Pebsworth cited “pressure from stakeholder groups,” though she didn’t specify which ones.

The committee members argued that the infection risk for most infants is minimal, and there hasn’t been enough research to confirm the vaccine’s safety for newborns. Many felt healthcare providers haven’t adequately informed parents about the pros and cons of administering the birth dose.

While the committee showed interest in expert opinions, they overlooked repeated advice to maintain the original recommendation.

The CDC frequently adopts the committee’s recommendations, which guide vaccination practices. However, without a permanent director currently in place, O’Neill will make the final call.

Earlier this year, President Kennedy dismissed all previous committee members, replacing them with those who hold anti-vaccine views.

Understanding Hepatitis B and Delayed Dosing

Hepatitis B is a significant liver infection that can be acute for many but may lead to more severe issues for infants and children. The virus can be spread through sexual contact, but it can also be transmitted from an infected mother to her child.

Initially, a committee recommended administering the first dose of the hepatitis B vaccine at birth in 1991, a practice that has effectively reduced the number of infections in children. Still, some members of the new committee expressed hesitation about automatically vaccinating all newborns, stating that previous research on safety was limited, and more extensive studies might provide clearer guidance.

Despite this, some members noted no evidence indicating that giving the vaccine at birth is harmful, suggesting that concerns were speculative.

Some committee members raised questions about the justification for delaying the initial dose for many infants.

One member remarked that the rapid vaccination approach was essential for infection prevention, while another viewed the proposed delay as misguided.

Concerns Over the New Direction

Experts worry that the committee’s focus has shifted to individual vaccine pros and cons rather than considering the broader public health impact. Critics of the recent changes pointed out that CDC scientists are no longer presenting data on vaccine safety during committee meetings, and this raises concerns about the integrity of the discussions.

Elizabeth Jacobs, representing Defend Public Health, described the committee’s current operations as unscientific and termed the recent meeting an “epidemiological crime scene.”

Senator Bill Cassidy, who has a medical background, labeled the committee’s choice a “mistake,” emphasizing that it could worsen public health outcomes.

A presentation by attorney Aaron Siri, known for vaccine litigation, was part of the meeting, and he suggested that the committee should not recommend the vaccine at all. This sparked a strong rebuttal from committee member Dr. Meisner, who felt Siri’s input was inappropriate.

Organizers claimed they had also invited several pro-vaccine experts to provide a balanced view, but some felt they were left out of critical discussions.

Dr. Hotez, involved in vaccine advocacy, stated he didn’t participate due to a perceived shift away from evidence-based practice.